NCT02365597 2026-01-30
An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer
Janssen Research & Development, LLC
Phase 2 Active not recruiting
Clinical Trials
8 trialsNCT04557449 2025-10-01
CDK4i
Pfizer
Phase 2 Active not recruiting
NCT05518799 2023-05-22
CYP3A4 Activity in Patients With Prostate Cancer Versus Male Patients With Other Solid Tumours
The Netherlands Cancer Institute
Phase NA Completed
NCT03237416 2018-11-06
Drug-drug-interaction Study to Assess the Effect of Darolutamide on the Pharmacokinetics of Probe Substrates of CYP3A4 and P-gp in Healthy Male Volunteers
Bayer
Phase 1 Completed
NCT01911728 2017-06-26
Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates
Astellas Pharma Inc
Phase 1 Completed
NCT03029676 2017-01-24
The Assessment of POCD After TURBT Under Spinal Anesthesia
Medical University of Warsaw
Phase 4 Unknown
NCT01402089 2016-02-02
Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients
Cantonal Hospital of St. Gallen
Phase 4 Completed
NCT01998685 2014-11-06
Prothrombotic Factors and Anaesthesia in Prostate Cancer
Regina Elena Cancer Institute
Phase NA Completed